Journal of the American Society of Hypertension
Volume 3, Issue 2 , Pages 119-132 , March 2009

Purification and mechanism of action of “cortexin,” a novel antihypertensive protein hormone from kidney and its role in essential hypertension in men

  • Somashree Chakraborty, MSc

      Affiliations

    • Sinha Institute of Medical Science & Technology, Garia, Calcutta, India
  • ,
  • Gausal A. Khan, PhD

      Affiliations

    • Sinha Institute of Medical Science & Technology, Garia, Calcutta, India
  • ,
  • Soumendra K. Karmohapatra, MSc

      Affiliations

    • Sinha Institute of Medical Science & Technology, Garia, Calcutta, India
  • ,
  • Rabindra Bhattacharya, MBBS, DTMH

      Affiliations

    • Calcutta Medical College and Hospital, Calcutta, India
  • ,
  • Gorachand Bhattacharya, MBBS, MD

      Affiliations

    • Calcutta National Medical College and Hospital, Calcutta, India
  • ,
  • A. Kumar Sinha, DSc

      Affiliations

    • Sinha Institute of Medical Science & Technology, Garia, Calcutta, India
    • Corresponding Author InformationCorresponding author: A. Kumar Sinha, DSc, Sinha Institute of Medical Science & Technology, 288 Kendua Main Road, Garia, Calcutta 700084, India. Tel: +91 99 03792100; fax: +91 33 24127905.

Received 9 September 2008 ,Accepted 20 November 2008.

References 

  1. Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet. 2007;370:591–603
  2. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291–1297
  3. Furman MI, Benoit SE, Bernard MR, Valeri CR, Borbone ML, Becker RC, et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol. 1998;31:352–358
  4. Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther. 1986;237:893–900
  5. Vural P, Cevik A, Curgunlu A, Canbaz M. Effects of diabetes mellitus and acute hypertension on plasma nitric oxide and endothelin concentrations in rats. Clin Chim Acta. 2002;320:43–47
  6. Kanowitz PJ. Evidence for the inhibitory role of guanosine 3,5,-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 1981;57:946–955
  7. Ridao N, Luño J, Garcia de Vinuesa S, Gomez F, Tejedor A, Valderrábano F. Prevalence of hypertension in renal disease. Nephrol Dial Transplant. 2001;16:S70–S73
  8. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol. 2007;294:F1–F9
  9. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. In: Harrison's principles of international medicine. Vol. II. 16th ed. New York, New York: McGraw-Hill Medical Publishing Division; 2005;p. A1–A15
  10. Guha M, Biswas J, Tirkey J, Sinha AK. Impairment of stimulation by estrogen of insulin-activated nitric oxide synthase in human breast cancer. Int J Cancer. 2002;100:261–265
  11. Dutta-Roy AK, Sinha AK. Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets. J Biol Chem. 1987;262:12685–12691
  12. Laemmli UK. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature. 1970;27:680–685
  13. Hochstrasser DF, Patchornik A, Merril CR. Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal Biochem. 1988;173:412–423
  14. Ling V, Guzetta AW, Canova-Davis E, Stults JT, Hancock WS. Characterization of the tryptic map of recombinant DNA derived tissue plasminogen activator by high-performance liquid chromatography-electrospray ionization mass spectrometry. Anal Chem. 1991;63:2909–2915
  15. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142–161
  16. Sinha AK, Bhattacharya S, Acharya K, Majumder S. Stimulation of nitric oxide synthesis and protective role of insulin in acute thrombosis in vivo. Life Sci. 1999;65:2687–2696
  17. Jia L, Bonaventura C, Bonaventura J, Stamler SJ. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996;380:221–226
  18. Cox RD, Frank CW. Determination of nitrate and nitrite in blood and urine by chemiluminescence. J Anal Toxicol. 1982;6:148–152
  19. Tlaskalova-Hogenova H, Stepankova R. Development of antibody formation in germ-free and conventionally reared rabbits: the role of intestinal lymphoid tissue in antibody formation to E. coli antigens. Folia Biol (Praha). 1980;26:81–93
  20. Engvall E, Perlman P. Enzyme-linked immunosorbent assay, ELISA. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol. 1972;109:129–135
  21. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem. 1987;262:10035–10038
  22. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. NIH. Current protocol in immunology, Vol 1, Section 5.8., Wiley Interscience, New York, 1991.
  23. Baelde HJ, Cleton-Jansen AM, van Beerendonk H, Namba M, Bovee JV, Hogendoorn PC. High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma. J Clin Pathol. 2001;54:778–782
  24. Zimmerman R, Paluch U, Sprinzl M, Neupert W. Cell-free synthesis of the mitochondrial ADP/ATP carrier protein of Neurospora crassa. Eur J Biochem. 1979;99:247–252
  25. Gilman AG. Protein binding assays for cyclic nucleotides. Adv Cyclic Nucleotide Res. 1972;2:9–24
  26. Chakraborty K, Khan GA, Banerjee P, Ray U, Sinha AK. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Platelets. 2003;14:421–427
  27. Vila-Petroff MG, Younes A, Egan J, Lakatta EG, Sollott SJ. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res. 1999;84:1020–1031
  28. Sakuma I, Stuehr DJ, Gross SS, Nathan C, Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988;85:8664–8667
  29. Lorenzo Fernández P, Mediavilla A, Moreno A, Catrillo M, Lorenzo-Velazquez B. Pharmacological aspects of sodium nitroprusside. Arch Inst Farmacol Exp (Madr). 1971;23:1–51
  30. Karsten AJ, Derouet H, Ziegler M, Eckert RE. Involvement of cyclic nucleotides in renal artery smooth muscle relaxation. Urol Res. 2003;30:367–373
  31. Bhattacharya S, Chakraborty Patra S, Basu Roy S, Kahn NN, Sinha AK. Purification and properties of insulin-activated nitric oxide synthase from human erythrocyte membranes. Arch Physiol Biochem. 2001;109:441–449
  32. In:  Gove PB,  Artin E,  Bethel JP,  Cook D,  Driscoll AM,  Goepp PH, et al. editor. 1986. Webster's Third New International Dictionary. Springfield, Massachusetts: Merriam-Webster, Inc, Publishers; 1986;

 See accompanying Editorial on page 76.

 Conflict of interest: none.

PII: S1933-1711(08)00218-0

doi: 10.1016/j.jash.2008.11.002

Journal of the American Society of Hypertension
Volume 3, Issue 2 , Pages 119-132 , March 2009